Journal of Leukemia & Lymphoma 2008 Issue 5 Central nervous system myelomatosis

Central nervous system myelomatosis
WANG Xue-wen

..............page:395-398

Advance in the impact of mesenchymal stem cells on tumor growth
DING Ye;LU Hua

..............page:398-400

jian xun qi shi

..............page:327

zhong hua yi xue hui bai xue bing lin ba liu za zhi gao yue

..............page:前插1

Advance of treatment for newly diagnosed multiple myeloma
ZHANG Xiao-wei;CHEN Wen-ming

..............page:391-394

Therapeutic options for newly diagnosed multiple myeloma
HOU Jian;FAN Jian-ling

..............page:389-391

di ji liang sha li du an lian he hua liao zhi liao duo fa xing gu sui liu 25 li
tao xiao ming ; zhang hua ; li hu sheng ; feng cui ; bin yan cheng

..............page:387-388

mei fa lun jia vad fang an zhi liao duo fa xing gu sui liu 32 li
zhang hong tao ; he yong chun ; zhang yan fang ; zhao fang ; zhang li dong

..............page:386-387

zao xue gan xi bao yi zhi huan zhe de xin li fan ying he xin li gan yu
niu qiao hong

..............page:384-386

yi ya shen suan wei zhu de si lian liao fa zhi liao nan zhi xing duo fa xing gu sui liu 11 li
yao jin xiao ; wei xu dong ; zhang yan li ; fang bai jun ; fu yue wen ; li yu fu ; zhu xing hu ; song yong ping

..............page:383-384

yi zuo rou bi xing wei zhu lian he hua liao fang an zhi liao fei huo qi jin lin ba liu de lin chuang guan cha
qin ling ; zhang hua ; huang chao gang

..............page:381-382

peng ti zuo mi zhi liao duo fa xing gu sui liu suo zhi xue xiao ban jian shao er li xue xiao ban bian hua gui lv bing wen xian fu xi
song lu zuo ; chang chun kang ; li xiao ; pu quan

..............page:379-381

yi hui yin bu bao kuai wei zhu yao biao xian de zi ran sha shang xi bao bai xue bing yi li
gu zuo ; guo feng li ; yang li ; ma li

..............page:378-379

peng ti zuo mi lian he di sai mi song huo hua liao zhi liao duo fa xing gu sui liu liao xiao guan cha
ma liang ming ; qiao zhen hua ; yang lin hua ; kang jian min ; hou li hong ; wang tao ; zheng zhuan zhen ; cheng xiang li

..............page:376-377

peng ti zuo mi lian he hua liao zhi liao yuan fa xing jiang xi bao bai xue bing yi li bing wen xian fu xi
chen yu ; chen tong ; xie yan zuo ; xu xiao ping

..............page:374-376

duo fa xing gu sui liu zhong shu shen jing xi tong jin run er li bing wen xian fu xi
leng zuo ; chen shi lun ; chen wen ming

..............page:372-374

Correlation of vascular endothelial growth factor with metastasis of non-Hodgkin lymphoma
LI Xi;ZHANG Qiao-hua;HOU Shu-ling

..............page:369-371

Expression of MIB1 and Topo Ⅱα and their relation with prognosis
WANG Shan;WANG Jin-fen;WANG Guo-ping

..............page:367-368,371

Outcome of childhood acute promyelocytic leukemia treated with all-trans-retinoic acid and chemotherapy
PEI Ren-zhi;MA Jun-xia;LIU Xu-hui;DU Xiao-hong;ZHANG Pei-sheng;CHEN Dong;CHEN Zhe;FANG Ya-hui;CHEN Dong;CHEN Lie-guang;LI Shuang-yue;CAO Jun-jie;SHA Ke-ya

..............page:364-366

Clinical analysis of mixed acute leukemia
SHEN Yuan-yuan;ZHAI Zhi-min;LI Qing;ZHU Wei-bo;XU Xiu-cai;SUN Zi-min;WU Zhi-wei;WU Jing-sheng

..............page:361-363

Effect of treatment by bortezomib together with dexamethsone to the refractory multiple myeloma
HE Juan;LI Jie;L(U) Xiao-yi;WANG Bai-xun;ZHAI Ming

..............page:359-360

Analysis on curative effects of multiple myeloma using small dose of thalidomide and chemotherapy
HE Ai-li;ZHANG Wang-gang;YANG Yun;CAO Xing-mei;WANG Jian-li

..............page:356-358

A continuous low-dose cyclophosphamide and prednisone regimen for multiple myeloma with severe complications
ZHOU Fan;HOU Jian;SHI Hao-tian;ZOU Jian-feng;WEI Wei;ZHANG Yi-zi;YANG Sheng-ling

..............page:353-355

TAD regimen with melphalan to treat 18 cases of multiple myeloma
CHEN Li-mei;LI Chao-min;WANG Huai-yu;GUAN Jion-hong;MA Xiao-li

..............page:351-352,355

The expression of serum MUC1 in multiple myeloma
WANG Xin;ZHANG You;YANG Hong;GAO Chun-lin;MOU Hong

..............page:348-350

A report of 9 multiple myeloma patients with extramedullary and extraosseous plasmocytoma and literature review
GAO Wen;CHEN Wen-ming;CHEN Shi-lun

..............page:346-347,350

Comparison of DVd and VAdM in the treatment of newly diagnosed multiple myeloma
HUANG Bei-hui;LI Juan;ZHAO Ying;GU Jing-li;SU Chang;ZHANG Guo-cai;ZOU Wai-yi

..............page:342-345

Bone turnover markers in multiple myeloma
LIU Ai-jun;LIU Jin-wei;LI Li-hong

..............page:340-341,345

Expression and clinical significance of cyclooxygenase-2 in multiple myeloma
HU Ying;CHEN Shi-lun;HUANG Xiao-nan;AN Na

..............page:337-339

Construction and identification of eukaryotic expressing vector for multiple myeloma MUC1-2VNTR
LUO Yun-jiao;LIU Kun;LIU Yue-bo;YANG Hong;YAO Jin;SHAO Liang;ZHANG You

..............page:334-336

Effects of SDF-1 on the chemotaxis of cord blood AC133+ cells
MA Yan-ping;MA Lan;ZHAO Shao-dong;REN Hua;WANG Jun-lan;YANG Lin-hua

..............page:331-333

Current status and future prospects for multiple myeloma
HOU Jian

..............page:321-322

Core treatment strategy for multiple myeloma in China
CHEN Shi-lun

..............page:323-324

Bortezomib:a proteasome inhibitor in the treatment of multiple myeloma
CHEN Wen-ming

..............page:325-327

Anti-proliferation effect of peroxisome proliferator-activated receptor γ agonist on Raji cells and its mechanism
LIU Jia-jun;LIN Dong-jun;XIAO Ruo-zhi;PAN Xiang-lin;CHEN Chun-yan

..............page:328-330,333